United Therapeutics Corporation (UTHR)

Last Closing Price: 478.16 (2026-03-06)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

United Therapeutics Corporation (UTHR) had Net Income of $1.33B for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$3.18B
Net Income
$1.33B
$384.40M
$2.80B
$1.69B
$1.49B
$221.40M
$1.71B
$1.71B
$1.33B
$1.33B
$1.33B
$1.33B
$1.49B
$1.58B
44.30M
47.90M
$30.13
$27.86
Balance Sheet Financials
$3.70B
$1.73B
$4.18B
$7.88B
$560.60M
--
$223.20M
$783.80M
$7.10B
$6.98B
$7.10B
43.64M
Cash Flow Statement Financials
$1.56B
$-551.30M
$-1.15B
$1.70B
$1.56B
$-140.10M
$147.70M
--
--
Fundamental Metrics & Ratios
6.60
--
--
--
--
87.92%
46.89%
46.89%
49.58%
53.85%
41.94%
$1.04B
--
--
--
0.40
2.10
9.09
40.16
18.81%
19.12%
16.94%
18.81%
$162.60
$21.73
$32.59